EMERALD ADVISERS, LLC – Horizon Therapeutics Public Limited Company Transaction History
EMERALD ADVISERS, LLC portfolio value:
$1.45M
portfolio value
EMERALD ADVISERS, LLC quarter portfolio value change:
-22.40%
quarter
Horizon Therapeutics Public Limited Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -26.64% | -8.52K shares | -1.1M | $61.89 | 23.47K |
| Q2 2022 | share | Increase | +4.86% | 1.48K shares | -658K | $79.76 | 32.00K |
| Q1 2022 | share | Increase | +3.68% | 1.08K shares | 39K | $105.21 | 30.52K |
| Q4 2021 | share | Decrease | -7.56% | -2.40K shares | -316K | $108.26 | 29.43K |
| Q3 2021 | share | Decrease | -2.57% | -839 shares | 427K | $109.54 | 31.84K |
| Q2 2021 | share | 0.00% | 0 shares | 53K | $93.64 | 32.68K | |
| Q1 2021 | share | Decrease | -34.79% | -17.44K shares | -659K | $92.04 | 32.68K |
| Q4 2020 | share | Decrease | -92.16% | -589.44K shares | -46.01M | $73.15 | 50.12K |
| Q3 2020 | share | Decrease | -26.05% | -225.32K shares | 1.61M | $77.68 | 639.56K |
| Q2 2020 | share | Decrease | -29.41% | -360.30K shares | 11.78M | $55.58 | 864.89K |
| Q1 2020 | share | Increase | +1.51% | 18.26K shares | -7.40M | $29.62 | 1.22M |
| Q4 2019 | share | Decrease | -0.05% | -625 shares | 10.80M | $36.2 | 1.20M |
| Q3 2019 | share | Decrease | -7.90% | -103.51K shares | 1.33M | $27.23 | 1.20M |
| Q2 2019 | share | Increase | 0.00% | 1.31M shares | 31.54M | $24.06 | 1.31M |